Clinical Trials Directory

Trials / Completed

CompletedNCT02957942

rTMS in Spasmodic Dysphonia

Repetitive Transcranial Magnetic Stimulation in Spasmodic Dysphonia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
21 Years – 75 Years
Healthy volunteers
Accepted

Summary

Focal dystonia is a neurological movement disorder characterized by excessive involuntary muscle contractions of any body part. Spasmodic dysphonia (SD) is a type of focal dystonia characterized by excessive contraction of intrinsic muscles in the larynx, leading to difficulty in speaking and affecting effective communication. The cause of SD is unknown and there are no treatments that produce long-term benefits. Previous studies have suggested that SD and other focal dystonias are associated with decreased inhibition in sensorimotor areas in the brain. However, no studies have investigated the effects of modulating excitability of the laryngeal motor cortex in healthy individuals or SD. The goal of this pilot project is to determine if brain excitability of the laryngeal motor cortex can be changed with low-frequency inhibitory repetitive transcranial magnetic stimulation (rTMS) in individuals with SD and healthy controls. Considering that rTMS at low frequencies (≤1 Hz) produces lasting inhibition in the brain, and that SD is associated with decreased cortical inhibition, the purpose of this pilot study is to determine safety, feasibility and response to 1Hz rTMS to the laryngeal motor cortex in individuals with SD and healthy people. The results will help understand changes associated with the disorder, as well as contribute to the development of future clinical interventions for SD.

Conditions

Interventions

TypeNameDescription
DEVICE1Hz repetitive transcranial magnetic stimulation (rTMS)1 session of low-frequency rTMS (1Hz, 1200 pulses, 20 minutes)

Timeline

Start date
2017-01-01
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2016-11-08
Last updated
2020-10-01
Results posted
2020-10-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02957942. Inclusion in this directory is not an endorsement.